These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 14239623)

  • 1. INFLUENCE OF SKF525-A ON THE BEHAVIORAL AND ANTICHOLINESTERASE EFFECTS OF CERTAIN CARBAMATES.
    GOLDBERG ME; JOHNSON HE; KNAAK JB
    Biochem Pharmacol; 1964 Nov; 13():1483-8. PubMed ID: 14239623
    [No Abstract]   [Full Text] [Related]  

  • 2. POTENTIATION OF CHLORPROMAZINE-INDUCED BEHAVIOURAL CHANGES BY ANTICHOLINESTERASE AGENTS.
    GOLDBERG ME; JOHNSON HE
    J Pharm Pharmacol; 1964 Jan; 16():60-1. PubMed ID: 14106567
    [No Abstract]   [Full Text] [Related]  

  • 3. STUDIES ON THE EFFECT OF CHLORCYCLIZINE AND OTHER DRUGS ON THE TOXICITY OF SEVERAL ORGANOPHOSPHATE ANTICHOLINESTERASES.
    WELCH RM; COON JM
    J Pharmacol Exp Ther; 1964 Feb; 143():192-8. PubMed ID: 14163992
    [No Abstract]   [Full Text] [Related]  

  • 4. [CEREBRAL ACETYLCHOLINESTERASE ACTIVITY AND BEHAVIOR OF THE CONDITIONED RAT].
    MELCHIORRI P; MAFFEI F
    Arch Ital Sci Farmacol; 1963 Jul; 13():216-7. PubMed ID: 14191829
    [No Abstract]   [Full Text] [Related]  

  • 5. Inhibition of discrete avoidance behavior by three anticholinesterase agents.
    Goldberg ME; Johnson HE; Knaak JB
    Psychopharmacologia; 1965 Jan; 7(1):72-6. PubMed ID: 5830967
    [No Abstract]   [Full Text] [Related]  

  • 6. [STUDY OF THE ANTICHOLINESTERASE ACTIVITY OF THE NICOTINIC ESTER OF DIETHYLAMINOETHANOL].
    ROYER R; LAMARCHE M; DALICHAMPS P
    C R Seances Soc Biol Fil; 1963; 157():2048-50. PubMed ID: 14115657
    [No Abstract]   [Full Text] [Related]  

  • 7. [The pharmacological characteristics of the new anticholinesterase drug aminostigmine].
    Prozorovskiĭ VB; Pavlova LV; Suslova IM; Shchemeleva NI
    Eksp Klin Farmakol; 1992; 55(1):13-6. PubMed ID: 1305425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. THE ANTI-TUBOCURARINE EFFECTS OF PHYSOSTIGMINE, NEOSTIGMINE, AND EDROPHONIUM IN THE RAT.
    VANMAANEN EF
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1964 May; 248():195-203. PubMed ID: 14230233
    [No Abstract]   [Full Text] [Related]  

  • 9. [PARAMYON-INDUCED CONTRACTURE OF THE DORSAL MUSCLE OF A LEECH UNDER THE EFFECT OF ANTICHOLINESTERASE AGENTS].
    PODLESNAIA AI
    Biull Eksp Biol Med; 1963 May; 55():78-81. PubMed ID: 14077754
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparative behavioral effects of CNS cholinesterase inhibitors.
    Moss DE; Rodriguez LA; McMaster SB
    Pharmacol Biochem Behav; 1985 Mar; 22(3):479-82. PubMed ID: 4039451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. POST-TRIAL INJECTIONS OF AN ANTI-CHOLINESTERASE DRUG AND MAZE LEARNING IN TWO STRAINS OF RATS.
    STRATTON LO; PETRINOVICH L
    Psychopharmacologia; 1963 Oct; 5():47-54. PubMed ID: 14082381
    [No Abstract]   [Full Text] [Related]  

  • 12. [CHARACTERIZATION OF THE CHOLINESTERASE ACTIVITY IN VITRO OF SOME BIOLOGICAL MATERIALS OF VARIOUS ORIGINS BY SELECTIVE INHIBITORS OF TRUE CHOLINESTERASE].
    GESSA GL; VARGIU L; FERRARI W
    Boll Soc Ital Biol Sper; 1963 Sep; 39():986-8. PubMed ID: 14091358
    [No Abstract]   [Full Text] [Related]  

  • 13. MODIFICATION OF GANGLIONIC RESPONSES TO CHOLINOMIMETIC DRUGS FOLLOWING PREGANGLIONIC STIMULATION, ANTICHOLINESTERASE AGENTS AND PILOCARPINE.
    TAKESHIGE C; VOLLE RL
    J Pharmacol Exp Ther; 1964 Dec; 146():335-43. PubMed ID: 14254327
    [No Abstract]   [Full Text] [Related]  

  • 14. PSYCHOPHARMACOLOGICAL EFFECTS OF REVERSIBLE CHOLINESTERASE INHIBITION INDUCED BY N-METHYL 3-ISOPROPYL PHENYL CARBAMATE (COMPOUND 10854).
    GOLDBERG ME; JOHNSON HE; KNAAK JB; SMYTH HF
    J Pharmacol Exp Ther; 1963 Aug; 141():244-52. PubMed ID: 14060479
    [No Abstract]   [Full Text] [Related]  

  • 15. THE MODE OF ACTION OF NEOSTIGMINE AND PHYSOSTIGMINE ON THE GUINEA-PIG TRACHEALIS MUSCLE.
    CARLYLE RF
    Br J Pharmacol Chemother; 1963 Aug; 21(1):137-49. PubMed ID: 14066138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HUMAN TISSUE CHOLINESTERASES: RATES OF RECOVERY AFTER INHIBITION BY NEOSTIGMINE; MICHAELIS-MENTEN CONSTANTS.
    KITZ RJ
    Biochem Pharmacol; 1964 Sep; 13():1275-82. PubMed ID: 14221725
    [No Abstract]   [Full Text] [Related]  

  • 17. SPECIFICITY OF CARBAMATE-INDUCED ESTERASE INHIBITION IN MICE.
    BARON RL; CASTERLINE JL; FITZHUGH OG
    Toxicol Appl Pharmacol; 1964 Jul; 6():402-10. PubMed ID: 14223489
    [No Abstract]   [Full Text] [Related]  

  • 18. Synthesis and anticholinesterase activity of (-)-N1-norphysostigmine, (-)-eseramine, and other N(1)-substituted analogues of (-)-physostigmine.
    Yu QS; Atack JR; Rapoport SI; Brossi A
    J Med Chem; 1988 Dec; 31(12):2297-300. PubMed ID: 3193422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NEW SEDATIVE AND HYPOTENSIVE PHENYLPIPERAZINE ESTERS AND CARBAMATES.
    HAYAO S; SCHUT RN; STRYCKER WG
    J Med Chem; 1963 Mar; 6():133-5. PubMed ID: 14188783
    [No Abstract]   [Full Text] [Related]  

  • 20. Efficacy of antidotes and their combinations in the treatment of acute carbamate poisoning in rats.
    Stojiljković MP; Škrbić R; Jokanović M; Kilibarda V; Bokonjić D; Vulović M
    Toxicology; 2018 Sep; 408():113-124. PubMed ID: 30176331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.